Bulk peptide wholesale pricing is only comparable on a cost per milligram of net peptide basis, after water, counterion and purity are subtracted. The documents that matter are a lot-specific certificate of analysis with the actual RP-HPLC chromatogram and mass spectrum, not a template number.
- A vial labelled 100 mg contains peptide plus bound water plus counterion, so cost comparisons must run on net peptide content rather than gross weight.
- HPLC purity and net peptide content are separate measurements answering different questions, and a certificate omitting the second makes the quote incomparable.
- A purity figure with no chromatogram and no stated method conditions is a claim rather than a measurement.
- Independent identity and purity testing at an accredited laboratory costs far less than a bulk order and converts supplier trust into evidence.
- Most retest dates on research-grade peptide are conventions, not results of a stability study on that lot and container.
- Suppliers fall into manufacturers, repackagers and resellers, and only the first has direct knowledge of how a lot was made.
What wholesale means once you get past the word
The word covers at least three different businesses, and they are not interchangeable from a purchasing point of view. There is the contract manufacturer that runs solid-phase synthesis, purification and lyophilization in its own facility at gram to kilogram scale. There is the repackager, which buys purified bulk from one or more of those manufacturers and fills vials under its own label. And there is the reseller, which never handles the material at all and drop-ships from whoever quoted lowest that month.
All three will quote you a wholesale price. Only the first has direct knowledge of how the lot was made. The second can have excellent quality control if it tests incoming bulk itself, and none at all if it simply transcribes the manufacturer's certificate onto new letterhead. The third cannot answer a technical question without a phone call to a party you are not allowed to speak to.
So the first procurement question is not price. It is: who synthesized this lot, and did you test it yourself after it arrived? A supplier that answers plainly, including when the answer is "we buy purified bulk and run our own identity and purity confirmation on receipt", is easier to work with over time than one that gets vague. Vagueness at this stage predicts vagueness later, when a lot fails and someone has to decide whose problem it is.
Price per milligram of peptide, not per vial
A vial labelled 100 mg does not contain 100 mg of peptide. It contains 100 mg of solid, and that solid is peptide plus bound water plus counterion plus whatever process residues survived purification and lyophilization. The fraction that is actually your molecule is the net peptide content, and it is a separate number from chromatographic purity. Confusing the two is the most common reason two quotes that look 20% apart are really identical.
| Term | What it measures | Typical method | Effect on cost per mg |
|---|---|---|---|
| Gross weight | Total solid in the vial | Balance, fill record | The denominator most sellers price against |
| HPLC purity | Peak area of the main component relative to all detected peaks | RP-HPLC, usually UV at 214 or 220 nm | Says nothing about water or salt |
| Net peptide content | Percentage of the solid that is peptide backbone | Amino acid analysis, nitrogen determination, or HPLC assay against a reference standard | Directly scales the usable mass |
| Water content | Bound and residual moisture | Karl Fischer titration or loss on drying | Commonly 3 to 12% of a lyophilized cake |
| Counterion content | Trifluoroacetate or acetate carried from purification | Ion chromatography or fluorine NMR | Can be several percent by mass |
Worked comparison. Two suppliers quote a 100 mg vial of the same sequence.
Supplier A: 100 mg gross, net peptide 82%, HPLC purity 98.2%, price 400
usable peptide = 100 × 0.82 = 82 mg
cost = 400 ÷ 82 = 4.88 per mg peptide
Supplier B: 100 mg gross, net peptide 91%, HPLC purity 97.5%, price 430
usable peptide = 100 × 0.91 = 91 mg
cost = 430 ÷ 91 = 4.73 per mg peptide
Supplier B looked 7.5% more expensive and is marginally cheaper. Neither figure can be computed at all if the certificate omits net peptide content, which many do. When it is missing, ask; if it stays missing, treat the quote as incomparable rather than as favourable. The cost per mg calculator does this arithmetic across several quotes at once, including the purity adjustment where a protocol requires you to apply one.
The document set that should arrive with the lot
Documentation is where wholesale suppliers separate cleanly. The floor is a certificate of analysis that names the specific lot and is dated. Anything below that floor is an unidentified white powder with a hopeful label.
| Document | What it establishes | What to check |
|---|---|---|
| Certificate of analysis | Identity, purity, content, appearance, lot number, dates | Lot number matches the vial label exactly |
| RP-HPLC chromatogram | The purity number is a measurement, not an assertion | Column, mobile phases, gradient, detection wavelength, run time all stated |
| Mass spectrum | The molecule present has the expected mass | Observed mass against calculated average or monoisotopic mass; charge states sensible |
| Net peptide content result | The usable mass in the vial | Method named, not just a percentage |
| Water and counterion results | What the rest of the solid is | Karl Fischer or loss on drying; counterion species identified |
| Sequence statement | What was intended, in one-letter or three-letter code | Modifications, amidation, acetylation and disulfide bonds written out |
| Safety data sheet | Handling and transport information | Current format, compound-specific rather than generic |
Bioburden and bacterial endotoxin results appear on some certificates. They are legitimate laboratory specifications where a cell-based assay is sensitive to endotoxin, and they say nothing whatsoever about suitability for anything other than laboratory work. A supplier that presents an endotoxin figure as though it upgrades the material into something else is telling you about its marketing rather than its chemistry.
Our own baseline for what accompanies a lot is set out on the quality standard page, which is a more useful thing to compare a competitor against than a headline purity claim.
Reading a certificate critically
Purity is method-dependent, which is the part most buyers skip. A single reversed-phase gradient at 214 nm resolves most impurities in most sequences, and it will occasionally hide a deletion or an isomer that co-elutes with the main peak. Where the number matters, an orthogonal method resolves the question: a different column chemistry, or the same column at a different mobile-phase pH. USP General Chapter <621> sets out how chromatographic system suitability is established and what may be adjusted without revalidating, which is the reference point for judging whether a stated method is coherent.
Some practical tells, gathered from certificates that turned out to be decorative:
- A purity figure with no chromatogram attached. That is a claim.
- Identical retention times on certificates for chemically different compounds, which usually means one template and a copy-paste habit.
- Date of analysis earlier than the stated date of manufacture.
- Chromatogram axes cropped so the baseline near the main peak cannot be seen.
- "Purity >99%" where the integration table shows peaks totalling 98.4%.
- A retest or expiry date with no reference to any stability study, which is a convention rather than a measurement.
None of these is proof of bad material. Each is a reason to ask a question and to note how the answer arrives. ICH Q2 describes what validation of an analytical procedure requires in terms of specificity, accuracy, precision and range; a supplier whose staff can discuss their method in those terms is a different proposition from one who forwards a PDF.
Evaluating a supplier without taking their word for it
Ask for the chromatogram of the current lot before you commit to a bulk quantity, not after. A supplier holding real data can send it the same day. Then ask what happens if your own testing disagrees with theirs. The useful answer describes a process: retention samples held from every lot, a defined window for raising a discrepancy, and who pays for the reanalysis.
Independent verification costs a fraction of a bulk order. Sending a vial to a contract analytical laboratory for identity by LC-MS and purity by RP-HPLC is routine work, and it converts a supplier relationship from trust to evidence. Laboratories accredited to ISO/IEC 17025 for the relevant methods are the ones whose report will hold up in a dispute. Do this on the first order from any new source, and again whenever a supplier changes the manufacturing site behind a product.
Other questions that earn their keep at wholesale scale: is a large order filled from a single lot or blended across several, and will the lot number be recorded per shipment. What is the fill tolerance on a stated vial weight. Are vials filled under an inert headspace. Will they notify you if the synthesis route or the counterion changes, since a switch from trifluoroacetate to acetate shifts net peptide content and can shift solubility behaviour in a buffer you have already validated.
Red flags that repeat across the market: prices far below the cost of the raw amino acids and resin, no lot numbers anywhere, refusal to name any analytical method, claims about what the compound does in a body, and payment routes with no recourse. Any language about therapeutic effect on a laboratory product tells you the seller has a different customer in mind than you.
Shipping, receipt and the first ten minutes
Lyophilized peptide travels as a dry solid because a dry solid tolerates ambient excursions that a solution would not survive. That does not make transit conditions irrelevant. Agree in writing what packaging is used, whether cold packs or dry ice accompany the shipment, and what documentation crosses the border with it. Customs paperwork that describes the contents accurately, with the correct tariff classification and a research-use declaration, prevents most of the delays that damage material by simply keeping it somewhere warm for a week. Our current arrangements are described under shipping.
Receipt inspection is a short written procedure worth having. Confirm the lot number on each vial against the certificate and the packing list. Confirm the seal is intact and the cake looks dry, intact and the expected colour. Record the temperature of the shipment on arrival if the specification calls for cold transport, including the state of any coolant. Photograph anything anomalous before you move it. Then log the lot into your inventory with the certificate attached, so that six months later a result can be traced back to a specific document rather than to a memory.
Diluent is part of the same procurement question and is often bought carelessly. Whatever is used to bring material into solution has its own lot number, its own certificate and its own expiry, and it belongs in the same record; the notes on bacteriostatic water cover what that documentation looks like.
Terms worth fixing before a repeat order
Repeat purchasing is where unwritten assumptions get expensive. The items below are ordinary commercial terms, and asking for them tends to sort suppliers quickly.
- Minimum order quantity and the price break structure, in writing, with the net peptide basis stated.
- Whether a quantity is supplied from one lot, and a price for insisting on it.
- Right of rejection within a stated number of days after independent testing.
- Retention of a sample from each lot by the supplier, and for how long.
- Change notification for synthesis site, route, counterion or fill format.
- Vial format, closure type, fill tolerance and labelling content.
- What the stated retest date is based on, and whether any stability data exists for that container and condition.
The last one usually produces an honest shrug. Most research-grade material carries a retest date by convention rather than by study, and a supplier who says so is more reliable than one who invents a justification. If a project depends on a defined shelf life, that study has to be run on the lot in question by someone, and the cost belongs in the project budget rather than in an assumption.
How do you buy peptides in bulk?
By agreeing a specification first and a price second. A bulk order commits you to many vials of one lot, so the questions that matter are which lot, tested by whom, against what specification, and what happens if the certificate does not match what arrives.
Minimum order quantities and tiered pricing follow from that rather than leading it. A quote given before anyone has named a purity method or a net peptide content basis is a number with no product attached, and two such quotes cannot be compared with each other.
The practical sequence is unglamorous. Ask for a certificate from a recent lot, confirm the accession number resolves at the issuing laboratory, then discuss quantity. Doing it the other way round is how buyers end up committed to a price for material they have no analytical record of.
Regulatory position
Peptides supplied for laboratory work are not medicines and are not manufactured under the pharmaceutical quality systems that govern approved products. A certificate of analysis addressing identity, purity and content is a narrower claim than lot release under a marketing authorisation, and no purity figure converts one category into the other. Where an approved medicine containing the same active molecule exists, it is a different product made under a different regime and available only on prescription.
Import and resale of research chemicals is governed by customs classification, controlled-substance scheduling where applicable, and the accuracy of the research-use declaration on the paperwork. Suppliers that market laboratory material with therapeutic language are creating a regulatory exposure that follows the buyer as well as the seller.
Status verified 26 August 2026.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Common questions
Why do two quotes for the same vial size differ so much?
Is HPLC purity the same as net peptide content?
Should we independently test material we have already bought?
What does a certificate of analysis fail to tell us?
Does a supplier holding ISO certification guarantee the material?
What counts as bulk peptide?
Why do quotes for the same compound vary so widely?
What is the difference between purity and peptide content?
What should a certificate of analysis include for a bulk lot?
Is TFA or acetate the standard salt form?
What is the minimum order to get real bulk pricing?
Is it cheaper to buy raw peptide powder and fill vials myself?
Sources
- United States Pharmacopeia, General Chapter <621> Chromatography. Defines system suitability requirements and permitted method adjustments for chromatographic procedures; the reference for judging whether a stated HPLC purity method is coherent.
- ICH Q2 guideline on validation of analytical procedures. Establishes the specificity, accuracy, precision and range criteria against which a supplier's purity and content methods can be assessed.
- ISO/IEC 17025, general requirements for the competence of testing and calibration laboratories. Supports the point that accreditation applies to named methods within a defined scope rather than to a supplier or product generally.
- PubChem compound records maintained by the National Library of Medicine. Source for calculated molecular formula and average and monoisotopic mass values used when checking an observed mass spectrum against expectation.